A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

  1. Hajek, R.
  2. Pour, L.
  3. Ozcan, M.
  4. Martin Sánchez, J.
  5. García Sanz, R.
  6. Anagnostopoulos, A.
  7. Oriol, A.
  8. Cascavilla, N.
  9. Terjung, A.
  10. Lee, Y.
  11. Briso, E.M.
  12. Dobkowska, E.
  13. Hauns, B.
  14. Špička, I.
Journal:
European Journal of Haematology

ISSN: 1600-0609,  0902-4441

Year of publication: 2020

Volume: 104

Issue: 5

Pages: 435-442

Type: Article

DOI: 10.1111/EJH.13377 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus